Active Ingredient(s): Busulfan
FDA Approved: * February 4, 1999
Pharm Company: * PDL BIOPHARMA INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Busulfex Overview

Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. Contents 1 History 2 Indications 3 Availability 4 Side effects 5 Dosing, administration, and pharmacokinetics 6 Drug interactions 7 Pharmacology 8 Complexation 9 References 10 External links History B...

Read more Busulfex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Busulfan

Recent Busulfex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 6mg/ml
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Busulfex: (2 results)

Sorted by National Drug Code
  • 59148-047 Busulfex 6 mg/ml Intravenous Injection by Otsuka America Pharmaceutical, Inc.
  • 59148-070 Busulfex 6 mg/ml Intravenous Injection by Otsuka America Pharmaceutical Inc.

Other drugs which contain Busulfan or a similar ingredient: (2 results)